Article citationsMore>>

Ramlau, R., Zatloukal, P., Jassem, J., Schwarzenberger, P., Orlov, S.V., Gottfried, M., Pereira, J.R., Temperley, G., Negro-Vilar, R., Rahal, S., Zhang, J.K., Negro-Vilar, A. and Dziewanowska, Z.E. (2008) Randomized Phase III Trial Comparing Bexarotene (L1069-49)/Cisplatin/Vinorelbine with Cisplatin/Vinorelbine in Chemotherapy-Naive Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer: SPIRIT I. Journal of Clinical Oncology, 26, 1886-1892.
http://dx.doi.org/10.1200/JCO.2007.12.2614

has been cited by the following article:

• TITLE: Alterations in Retinoic Acid Receptors in Non-Small Cell Lung Cancer and Their Clinical Implications

  AUTHORS: Saé Muñiz-Hernández, Norma Hernández-Pedro, Omar E. Macedo-Pérez, Oscar Arrieta

  KEYWORDS: Cell Transformation, Neoplastic, Neoplasms, Receptors, Retinoic Acid, Biological Markers, Retinoids

  JOURNAL NAME: Journal of Cancer Therapy, Vol.6 No.8, July 28, 2015

  ABSTRACT: The nuclear retinoic acid receptor may play a critical role in the process of lung carcinogenesis. Alteration or loss of nuclear retinoic acid receptors (RARs) has been associated with progression in premalignant and malignant tissues and it is associated with malignant transformation in human cells. Vitamin A derivates, such as retinoic acid, have emerged as adjuvant to therapy in several types of cancer with favorable effects. Retinoic acid regulates the expression of target genes through the binding and activation of RARs, inhibiting growth proliferation. Diverse studies have evaluated different retinoids alone or in combination with chemotherapy in lung cancer, from which results have been controversial with benefits observed only in the subpopulation with high levels of triglycerides. Additionally, several large randomized trials using retinoids to prevent tobacco-related cancer have failed; due to the latter the use of retinoids in clinical trials remains controversial. However they could reduce the risk of cancer development in non-smokers. There is evidence that retinoids have different effects on lung cancer; still the identification of biomarkers could determinate their benefits as preventive or therapy agents. This review describes the RAR alterations during the development of Non-Small Cell Lung Cancer and sets out the importance of several cancer treatments with retinoid compounds.